Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-25 to 2024-04-15
Current total value of award: $10316.36
Description: 4564097435!TYSABRI 300 MG/15 ML VIAL 15ML